Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ProQR Therapeutics N.V. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
PRQR
Nasdaq
2830
www.proqr.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ProQR Therapeutics N.V.
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
- Jan 8th, 2026 6:00 am
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are individual investors with 34% stake, while 29% is held by institutions
- Dec 28th, 2025 6:41 am
ProQR to Participate in 8th Annual Evercore Healthcare Conference
- Dec 1st, 2025 6:00 am
Faron Pharmaceuticals Ltd: Appointment of CFO
- Dec 1st, 2025 12:15 am
ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates
- Nov 6th, 2025 6:10 am
ProQR: Q3 Earnings Snapshot
- Nov 6th, 2025 5:08 am
ProQR Announces Third Quarter 2025 Operating and Financial Results
- Nov 6th, 2025 5:00 am
Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates
- Oct 28th, 2025 6:20 am
ProQR to Participate in Upcoming Investor Conferences in October 2025
- Oct 13th, 2025 6:30 am
ProQR Therapeutics Second Quarter 2025 Earnings: Misses Expectations
- Aug 9th, 2025 6:13 am
ProQR: Q2 Earnings Snapshot
- Aug 8th, 2025 12:02 pm
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates
- Aug 7th, 2025 6:40 am
ProQR Announces Second Quarter 2025 Operating and Financial Results
- Aug 7th, 2025 5:00 am
ProQR Announces Upcoming Presentation at RNA Editing Summit
- Jul 28th, 2025 6:00 am
Owning 32% shares,institutional owners seem interested in ProQR Therapeutics N.V. (NASDAQ:PRQR),
- Jul 21st, 2025 4:28 am
ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
- Jun 26th, 2025 2:30 pm
ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
- May 12th, 2025 6:00 am
New Forecasts: Here's What Analysts Think The Future Holds For ProQR Therapeutics N.V. (NASDAQ:PRQR)
- May 9th, 2025 4:43 am
ProQR Announces First Quarter 2025 Operating and Financial Results
- May 8th, 2025 5:00 am
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
- May 2nd, 2025 6:00 am
Scroll